# The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction

> **NCT03893435** · NA · COMPLETED · sponsor: **The Young Investigator Group of Cardiovascular Research** · enrollment: 192 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Sacubitril / Valsartan Oral Tablet [Entresto]

## Key facts

- **NCT ID:** NCT03893435
- **Lead sponsor:** The Young Investigator Group of Cardiovascular Research
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03893435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03893435, "The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03893435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*